SG Americas Securities
NXTC icon

SG Americas Securities’s NextCure NXTC Stock Holding History

SG Americas Securities’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,959
Closed -$320K – 3682
2021
Q3 		$320K Sell
3,959
-8,713
-69% -$764K ﹤0.01% 2882
2021
Q2 		$1.22M Sell
12,672
-13,990
-52% -$1.43M 0.01% 1428
2021
Q1 		$3.2M Buy
+26,662
New +$3.86M 0.02% 745
2020
Q3 		– Sell
-2,819
Closed -$725K – 3218
2020
Q2 		$725K Buy
2,819
+2,535
+893% +$965K 0.01% 1734
2020
Q1 		$126K Buy
+284
New +$152K ﹤0.01% 2821

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities's NXTC Position: Q4 2021 in Review

SG Americas Securities sold out of NextCure (NXTC) in Q4 2021, closing a stake of 3,959 shares — an estimated $320K sold.

SG Americas Securities first reported a position in NXTC in Q1 2020 and held it in 5 quarters. The position peaked at $3.2M in Q1 2021. 71 funds tracked by Wall St. Rank hold NXTC as of Q4 2021.

  • SG Americas Securities reported no remaining NextCure position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 3,959 NextCure shares in Q4 2021, an estimated $320K.
  • SG Americas Securities first reported a position in NextCure in Q1 2020 and held it in 5 quarters.
  • SG Americas Securities's NextCure position peaked at $3.2M in Q1 2021.
  • 71 funds tracked by Wall St. Rank held NextCure as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.